SEC Form 4 · accession 0001181431-15-005970
Pacira BioSciences, Inc. · PCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David M Stack
Officer — President, CEO and Chairman · Director
Period of report
Apr 15, 2015
Accepted (ET)
Apr 17, 2015 · 6:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001396814
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 15, 2015 | M | 25,000 | $1.61 | A | 25,059 | D | |
| Common Stock | Apr 15, 2015 | S | 25,000 | $90.499 | D | 59 | D | |
| Common StockF3 | holding | — | — | — | 18,596 | I | By Stack Schroon Mohawk FLP | |
| Common StockF1,F4 | holding | — | — | — | 1,208 | I | By LCK Investment LLC |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F5 | $1.61 | Apr 15, 2015 | M | 25,000 | D | — | Sep 2, 2020 | Common Stock | 25,000 | 115,695 | D |
Explanation of responses
- F1Reflects the transfer of an aggregate of 1,208 shares of common stock transferred by the reporting person to LCK Investment LLC in January and February 2015.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- F3Mr. Stack is the general partner of Stack Schroon Mohawk FLP.
- F4Mr. Stack and his wife are the owners of LCK Investment LLC.
- F5The option vested as to 50% of the option shares on February 2, 2011, 19,377 option shares vested on February 3, 2011, and the remaining option shares vested in successive equal monthly installments for the subsequent 19 months.